Rockefeller-Born, IPO-Validated, Ready for Scale.

With failure rates approaching 98% across the pharmaceutical industry, drug discovery process is in dire need of improvement at every stage. AI-driven discovery remains constrained by the same flawed datasets.

Invented in a Nobel Prize-winning laboratory at The Rockefeller University, our biotechnology fixes the fundamental starting point of drug discovery: the Cell itself. We engineer human-relevant disease models that generate reliable data for discovery and AI.

CONTACT | kambiz.shekdar@secondcellbio.com